Skip to Content

Breo Ellipta

In the US, Breo Ellipta (fluticasone/vilanterol systemic) is a member of the drug class bronchodilator combinations and is used to treat Asthma, Asthma - Maintenance, COPD and COPD - Maintenance.

US matches:

Ingredient matches for Breo Ellipta

Fluticasone

Fluticasone furoate (a derivative of Fluticasone) is reported as an ingredient of Breo Ellipta in the following countries:

  • Canada
  • United States

Vilanterol

Vilanterol trifenatate (a derivative of Vilanterol) is reported as an ingredient of Breo Ellipta in the following countries:

  • Canada
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide